Genetic risk factor found for Covid-19 smell and taste loss, researchers say
Six months after contracting Covid, as many as 1.6 million people in the U.S. are still unable to smell or have experienced changes in their ability to smell.
Study Supports Longer ADT Use With Radiation for High-Risk Prostate Cancer
The minimum duration of androgen deprivation therapy (ADT) that provides a distant metastasis-free survival benefit in patients with high-risk prostate cancer is more than 18 months for those receiving external beam radiotherapy (EBRT)...